[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR200102331T2 - P (1-Fenasi-3-fenil-3-piperidiletil): piperidin trevleri, bunlarìn elde edilmesi i‡in metodlar ve bunlarì i‡eren farmas”tik kompozisyonlar. - Google Patents

P (1-Fenasi-3-fenil-3-piperidiletil): piperidin trevleri, bunlarìn elde edilmesi i‡in metodlar ve bunlarì i‡eren farmas”tik kompozisyonlar.

Info

Publication number
TR200102331T2
TR200102331T2 TR2001/02331T TR200102331T TR200102331T2 TR 200102331 T2 TR200102331 T2 TR 200102331T2 TR 2001/02331 T TR2001/02331 T TR 2001/02331T TR 200102331 T TR200102331 T TR 200102331T TR 200102331 T2 TR200102331 T2 TR 200102331T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
compositions containing
phenaci
piperidylethyl
revs
Prior art date
Application number
TR2001/02331T
Other languages
English (en)
Inventor
Philippe Ducoux Jean
Emonds Alt Xavier
Gueule Patrick
Proietto Vincenzo
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9901593A external-priority patent/FR2789389B3/fr
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of TR200102331T2 publication Critical patent/TR200102331T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Mevcut buluç, P maddesi insan NK1, reseptörleri itibar yla yüksek afinite ile yüksek selektivite sergileyen (I) formülü bileçikleri ve bunlar n minera ya da organik asitler ile tuzlar , solvatlar ve/veya hidratlar ile ilgilidir. Buluç ayr ca bunlar n, bunlar n üretilmesinde faydal olan ara (VII) formülü bileçiklerinin ve belirtilen ürünleri içeren farmasötik kompozisyonlar n haz rlanmas yönelik bir metot ve P maddesi ve insan NK1 reseptörlerinin kar çt G tüm patolojilerin edilmesine yönelik ilaçlar n üretilmesindeki kullan mlar ile de ilgilidir.
TR2001/02331T 1999-02-10 2000-02-08 P (1-Fenasi-3-fenil-3-piperidiletil): piperidin trevleri, bunlarìn elde edilmesi i‡in metodlar ve bunlarì i‡eren farmas”tik kompozisyonlar. TR200102331T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9901593A FR2789389B3 (fr) 1999-02-10 1999-02-10 Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
FR9904429A FR2789390B3 (fr) 1999-02-10 1999-04-07 Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
TR200102331T2 true TR200102331T2 (tr) 2002-03-21

Family

ID=26234812

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02331T TR200102331T2 (tr) 1999-02-10 2000-02-08 P (1-Fenasi-3-fenil-3-piperidiletil): piperidin trevleri, bunlarìn elde edilmesi i‡in metodlar ve bunlarì i‡eren farmas”tik kompozisyonlar.

Country Status (37)

Country Link
US (2) US6642233B1 (tr)
EP (1) EP1150970B1 (tr)
JP (1) JP4648544B2 (tr)
KR (1) KR100611261B1 (tr)
CN (1) CN1273463C (tr)
AR (1) AR028813A1 (tr)
AT (1) ATE370942T1 (tr)
AU (1) AU763716B2 (tr)
BG (1) BG65031B1 (tr)
BR (1) BR0008067A (tr)
CA (1) CA2360894C (tr)
CO (1) CO4980896A1 (tr)
CZ (1) CZ300765B6 (tr)
DE (1) DE60036081T2 (tr)
DK (1) DK1150970T3 (tr)
EE (1) EE04437B1 (tr)
ES (1) ES2291187T3 (tr)
FR (1) FR2789390B3 (tr)
HK (1) HK1038927A1 (tr)
HR (1) HRP20010566A2 (tr)
HU (1) HUP0201281A3 (tr)
ID (1) ID29219A (tr)
IL (2) IL144363A0 (tr)
ME (1) MEP11908A (tr)
NO (2) NO321149B1 (tr)
NZ (1) NZ513053A (tr)
PE (1) PE20001463A1 (tr)
PL (1) PL198561B1 (tr)
PT (1) PT1150970E (tr)
RS (1) RS50210B (tr)
RU (1) RU2220956C2 (tr)
SI (1) SI1150970T1 (tr)
SK (1) SK286401B6 (tr)
TR (1) TR200102331T2 (tr)
TW (1) TWI254712B (tr)
UA (1) UA70986C2 (tr)
WO (1) WO2000047572A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003217535A1 (en) * 2002-02-20 2003-09-09 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
US20050009798A1 (en) 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
MXPA06008648A (es) * 2004-01-30 2006-09-04 Pfizer Prod Inc Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion.
FR2873373B1 (fr) * 2004-07-23 2006-09-08 Sanofi Synthelabo Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
GB2452696B (en) * 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
DE102008015425A1 (de) * 2008-03-20 2010-01-21 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid
DE102008015426A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen
DE102008015428A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US512901A (en) * 1894-01-16 Folding bed
GB821012A (en) * 1957-01-15 1959-09-30 Rhone Poulenc Sa New phenthiazine derivatives and processes for their preparation
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2132709T3 (es) * 1994-08-25 1999-08-16 Merrell Pharma Inc Nuevas piperidinas substituidas utiles para el tratamiento de las enfermedades alergicas.
EP0714891A1 (en) 1994-11-22 1996-06-05 Eli Lilly And Company Heterocyclic tachykinin receptor antagonists

Also Published As

Publication number Publication date
DK1150970T3 (da) 2007-12-17
AU763716B2 (en) 2003-07-31
PT1150970E (pt) 2007-11-07
CN1345317A (zh) 2002-04-17
CN1273463C (zh) 2006-09-06
US6951940B2 (en) 2005-10-04
ATE370942T1 (de) 2007-09-15
FR2789390A1 (fr) 2000-08-11
NO20051958L (no) 2001-10-10
EP1150970B1 (fr) 2007-08-22
WO2000047572A1 (fr) 2000-08-17
DE60036081D1 (de) 2007-10-04
YU56401A (sh) 2004-03-12
NZ513053A (en) 2002-10-25
US20040072840A1 (en) 2004-04-15
AU2553100A (en) 2000-08-29
ID29219A (id) 2001-08-16
US6642233B1 (en) 2003-11-04
CZ20012888A3 (cs) 2001-11-14
EP1150970A1 (fr) 2001-11-07
SI1150970T1 (sl) 2008-02-29
BG105794A (en) 2002-05-31
HUP0201281A3 (en) 2003-05-28
KR100611261B1 (ko) 2006-08-10
CA2360894A1 (en) 2000-08-17
UA70986C2 (uk) 2004-11-15
IL144363A0 (en) 2002-05-23
CZ300765B6 (cs) 2009-08-05
DE60036081T2 (de) 2008-05-15
NO20013878D0 (no) 2001-08-08
SK11392001A3 (sk) 2002-02-05
JP4648544B2 (ja) 2011-03-09
NO321149B1 (no) 2006-03-27
HRP20010566A2 (en) 2002-08-31
BR0008067A (pt) 2001-11-06
FR2789390B3 (fr) 2001-03-09
JP2002536442A (ja) 2002-10-29
BG65031B1 (bg) 2006-12-29
RU2220956C2 (ru) 2004-01-10
PL198561B1 (pl) 2008-06-30
ES2291187T3 (es) 2008-03-01
NO20013878L (no) 2001-10-10
TWI254712B (en) 2006-05-11
HUP0201281A2 (en) 2002-09-28
AR028813A1 (es) 2003-05-28
CO4980896A1 (es) 2000-11-27
MEP11908A (en) 2010-06-10
EE200100417A (et) 2002-12-16
PE20001463A1 (es) 2001-02-21
SK286401B6 (sk) 2008-09-05
CA2360894C (en) 2009-09-22
KR20010101818A (ko) 2001-11-14
HK1038927A1 (en) 2002-04-04
IL180579A0 (en) 2007-06-03
RS50210B (sr) 2009-07-15
PL350243A1 (en) 2002-12-02
EE04437B1 (et) 2005-02-15

Similar Documents

Publication Publication Date Title
FI941987A (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset
NO885352D0 (no) Vannloeselige camptothecin-analoger.
ATE247123T1 (de) Neue piperidin und piperazin-derivate als p2x7- rezeptor antagonisten
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
HUP0203514A2 (hu) Kinuklidin vegyületek és ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
ECSP055621A (es) Aza-biciclo-alquil-éteres y su uso como agonistas de alfa7-nachr
FR2903107B1 (fr) Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
HUP9904125A2 (hu) Tachikinin-receptor antagonista hatású 1-(1,2-diszubsztituált piperidinil)-4-szubsztituált piperidinszármazékok
NO974734L (no) Nye arylglycinamidderivater, fremgangsmåte for deres fremstilling og farmasaöytiske blandinger inneholdende disse forbindelser
AR038235A1 (es) Compuestos de espiropiperidina n-sustituidos como ligandos para el receptor orl-1
TR200102331T2 (tr) P (1-Fenasi-3-fenil-3-piperidiletil): piperidin trevleri, bunlarìn elde edilmesi i‡in metodlar ve bunlarì i‡eren farmas”tik kompozisyonlar.
FR2667068B1 (fr) Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0337136A3 (en) Piperidine derivatives in the treatment of extrapyramidal side effects associated with neuroleptic therapy
KR920007999A (ko) 4-또는 5-치환된 피리딘-2-카복실산. 이들의 제조방법 및 약제로서 이들의 용도
HUP0401563A2 (hu) Új piperidinarboxamid-származékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
AR011997A1 (es) Complejo basado en un compuesto de organosilicio y una composicion farmaceutica o cosmetica que lo incluye.
BR0317409A (pt) Compostos cicloalquileno amida 2-piridila e 2-pirimidila, composição farmacêutica compreendendo os mesmos e uso dos referidos compostos
IT1222414B (it) Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
ECSP951434A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos (ii)
ATE268775T1 (de) Diazepinecarboxamidderivate, verfahren zu ihrer herstellung ,ihre verwendung als arzneimittel, pharmazeutische zubereitungen und ihre verwendung
IT1232971B (it) Sali di antagonisti dei recettori h2, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono